Neuromodulation for treating blindness-causing diseases to which there are no cures and limited approved therapies, including: Retinitis Pigmentosa (RP), Macular Degeneration, and Stargardt\'s disease
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of ScyFIX plus 4917 other startups.
